Cocrystal Pharma (DE:8CC)
NASDAQ:8CC
Earnings Data
Report Date
Aug 17, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.14Last Year’s EPS
-0.17Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
DE:8CC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:8CC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 15, 2026 | €1.06 | €1.04 | -1.89% |
Mar 31, 2026 | €0.86 | €0.85 | -1.73% |
Nov 14, 2025 | €0.92 | €0.85 | -7.07% |
Aug 14, 2025 | €1.40 | €1.42 | +1.43% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cocrystal Pharma (DE:8CC) report earnings?
Cocrystal Pharma (DE:8CC) is schdueled to report earning on Aug 17, 2026, TBA (Confirmed).
What is Cocrystal Pharma (DE:8CC) earnings time?
Cocrystal Pharma (DE:8CC) earnings time is at Aug 17, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Cocrystal Pharma stock?
The P/E ratio of Cocrystal Pharma is N/A.
What is DE:8CC EPS forecast?
DE:8CC EPS forecast for the fiscal quarter 2026 (Q2) is -0.14.